Integrated Core Strategies (US) LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-15 4:19 pm Sale | 2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Integrated Core Strategies (US) LLC | 122,751 1.000% | -421,525 (-77.45%) | Filing |
| 2024-02-28 4:38 pm Purchase | 2024-02-23 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Integrated Core Strategies (US) LLC | 544,276 5.300% | 544,276 (New Position) | Filing |